TMAO compound may play role in cardiovascular disease risk

04/26/2013 | WebMD

Individuals with the highest levels of trimethylamine-N-oxide, a compound produced in the stomach, were 2.5 times more likely to suffer a heart attack, stroke or heart disease than those with the lowest TMAO levels, a study showed. The compound can make it more difficult for the liver and intestines to remove cholesterol, lead researcher Dr. Stanley Hazen of the Cleveland Clinic said. The findings were published in the New England Journal of Medicine.

View Full Article in:

WebMD

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Corporate Life Sciences Lawyer (3-5 years exp)
Ropes & Gray LLP
Boston, MA; San Francisco, CA; Silicon Valley, CA, MA
Director of Accreditation
Meridian Health Plan
Detroit, MI
Stop Loss Sales Executive, (Southern Region)
Indigo Insurance Services
Multiple Locations, SL_Multiple Locations
Health Services Researcher
AARP
Washington, DC
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO